We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Settings

Save and close

JAX Frontend Platform

gbrs

Gene Expression Database for Mouse Development named a Global Core Biodata Resource

Gene Expression Database for Mouse Development named a Global Core Biodata Resource

The Gene Expression Database for Mouse Development has been named a Global Core Biodata Resource in the 2023 selection round.

Read More
Applying AI and machine learning to complex research tasks

Applying AI and machine learning to complex research tasks

JAX researchers are at the forefront of developing and implementing AI-based technologies for a variety of research applications.

Read More
What happens to the brain after a stroke?

What happens to the brain after a stroke?

Mary Teena Joy investigates what happens to the brain after a stroke and how to enhance brain neural rewiring to improve recovery.

Read More
Examining the power and potential of the Cube

Examining the power and potential of the Cube

A synopsis of what The Cube Initiative is at JAX and why it may have a marked impact on the bridge between research and clinical application.

Read More
Shriners Hospitals for Children and JAX announce research affiliation

Shriners Hospitals for Children and JAX announce research affiliation

A new research affiliation agreement between Shriners Hospitals for Children (SHC) and JAX will endeavor to gain a greater understanding of the genetic factors involved in cerebral palsy.

Read More
The unexpected advantages of outbred mice in research

The unexpected advantages of outbred mice in research

Recently developed outbred mouse populations, such as the diversity outbred (DO) mice at The Jackson Laboratory (JAX), have created research options that parallel or even exceed human genetic diversity. Research with DO mice offers a full range of genetic diversity, and therefore more generalizability of responses across populations.

Read More
Developing new therapies for Alzheimer’s disease

Developing new therapies for Alzheimer’s disease

Alzheimer’s disease is still poorly understood despite its huge costs and burden. Greg Carter is working at the intersection between patient and mouse research to develop accurate disease models and develop effective therapies.

Read More

©2025 The Jackson Laboratory